Considerations for selecting and implementing comorbidity indices when using secondary data sources: a guide for health researchers
International Journal of Population Data Science · 2025
DOI: 10.23889/ijpds.v10i3.2973 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Population Data Science, 2025. Verfasst von Boglarka Soos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, T2N 4Z6. Hauptthemen laut MEDLINE: Comorbidity. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Comorbidity measures, such as the Charlson Comorbidity Index, are commonly used in risk adjustment models to account for variability in disease burden. This narrative synthesis describes and critiques available comorbidity indices and offers implementation guidance to researchers based on a critical review of existing literature. First, common comorbidity measures are described. Instruments derived using case definitions, grouping of International Classification of Diseases (ICD) codes, and mapping of dispensed medications to chronic conditions are presented. Comorbidity indices that combine diagnostic and medication data are also introduced. No single option consistently outperforms the rest. Next, important considerations when applying a comorbidity index are described. It is crucial to respect temporality and exclude health events that arise after the study index date. Researchers must also weigh the interpretability of using a weighted sum against the flexibility of using a large set of binary variables. When modelling long-term outcomes, there are benefits to applying a one-year look-back window and augmenting data via linkage. For short-term outcomes, certain chronic conditions may exhibit a protective association; however, not all indices capture these relationships. Implementation of these findings will improve the interpretability of comorbidity measures and the quality of future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, T2N 4Z6.
- Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, T2N 4Z6.
- Department of Family Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, T2N 4N1.
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, T2N 2T9.
- Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, T3B 6A8.
- Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, T2N 4N1.
Zitieren
APA
Soos, B., Williamson, T., McBrien, K., Wiebe, S., Tonelli, M., Southern, D. A., Eastwood, C. A., Li, B., Quan, H., & Ronksley, P. (2025). Considerations for selecting and implementing comorbidity indices when using secondary data sources: a guide for health researchers. International Journal of Population Data Science. https://doi.org/10.23889/ijpds.v10i3.2973
Vancouver
Soos B, Williamson T, McBrien K, Wiebe S, Tonelli M, Southern DA, et al. Considerations for selecting and implementing comorbidity indices when using secondary data sources: a guide for health researchers. International Journal of Population Data Science. 2025. doi:10.23889/ijpds.v10i3.2973
BibTeX
@article{Soos2025,
author = {Soos, Boglarka and Williamson, Tyler and McBrien, Kerry and Wiebe, Samuel and Tonelli, Marcello and Southern, Danielle A and Eastwood, Cathy A and Li, Bing and Quan, Hude and Ronksley, Paul},
title = {Considerations for selecting and implementing comorbidity indices when using secondary data sources: a guide for health researchers},
journal = {International Journal of Population Data Science},
year = {2025},
doi = {10.23889/ijpds.v10i3.2973}
}
EUVIMED